<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 28.2: Managing Multi-System Organ Involvement (MSOI)</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - RED/CRISIS theme for Crisis Management */
        .module-header {
            background: linear-gradient(135deg, #991b1b 0%, #dc2626 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #991b1b;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #991b1b;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #991b1b;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #fef2f2;
            border: 2px solid #ef4444;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #991b1b;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #991b1b;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #ef4444;
        }

        .term-item .term {
            font-weight: 700;
            color: #991b1b;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #991b1b;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #444;
            margin: 30px 0 15px 0;
            font-weight: 600;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #fee2e2 60%);
            padding: 0 4px;
            font-weight: 500;
            color: #991b1b;
        }

        /* Alert Boxes */
        .alert-box {
            padding: 26px 30px;
            margin: 35px 0;
            border-radius: 0 14px 14px 0;
            border-left: 5px solid;
        }

        .alert-box .alert-label {
            font-weight: 600;
            margin: 0 0 12px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .alert-box.warning {
            background: #fff8e6;
            border-left-color: #ff9800;
        }

        .alert-box.warning .alert-label {
            color: #e65100;
        }

        .alert-box.info {
            background: #e3f2fd;
            border-left-color: #2196f3;
        }

        .alert-box.info .alert-label {
            color: #1565c0;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #991b1b 0%, #dc2626 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
            letter-spacing: 0.5px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        /* Data Table */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        th {
            background: #f8f9fa;
            padding: 15px;
            text-align: left;
            font-weight: 600;
            border-bottom: 2px solid #991b1b;
            color: #991b1b;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #eee;
            vertical-align: top;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #991b1b 0%, #dc2626 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
            color: white;
        }

        .stat-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(180px, 1fr));
            gap: 25px;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 36px;
            font-weight: 700;
            margin-bottom: 5px;
        }

        .stat-label {
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 1px;
            opacity: 0.9;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .reveal-btn {
            background: #991b1b;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #fff;
            border-radius: 8px;
            border-left: 4px solid #991b1b;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            height: auto;
            margin-bottom: 15px;
        }

        .references-box {
            margin-top: 40px;
            padding: 25px;
            background: #f9f9f9;
            border-radius: 12px;
            font-size: 14px;
        }

        .references-box h4 {
            margin-top: 0;
            color: #991b1b;
        }

        .takeaways-box {
            background: #f0f4f8;
            border-radius: 12px;
            padding: 30px;
            margin: 40px 0;
        }

        .takeaways-box h4 {
            margin-top: 0;
            color: #1e40af;
            text-transform: uppercase;
            font-size: 14px;
            letter-spacing: 1px;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 28: Crisis & Complex Cases</p>
            <h1 class="lesson-title">Lesson 2: Managing Multi-System Organ Involvement (MSOI)</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 2 of 4</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>Pathophysiology of Systemic Overflow</a></li>
                <li><a href="#section2"><span class="section-num">2</span>The Prototype: Lupus Nephritis</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Vascular Emergencies: Scleroderma Crisis</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Coordinating the Multidisciplinary Team</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Advanced Root Cause Analysis (MSOI)</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Triage & Intervention Prioritization</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Analyze the mechanisms of "systemic overflow" where localized autoimmunity transitions to multi-organ failure.</li>
                <li>Identify the clinical hallmarks and integrative support strategies for Lupus Nephritis and Scleroderma Renal Crisis.</li>
                <li>Master the communication protocols required to coordinate care between specialized medical teams (Nephrology, Rheumatology, Pulmonology).</li>
                <li>Apply the C.A.L.M. Protocolâ„¢ to identify high-intensity systemic triggers (Advanced 'A').</li>
                <li>Prioritize interventions when multiple physiological systems are compromised simultaneously.</li>
            </ul>
        </div>

        <div class="welcome-box">
            <p>In Lesson 1, we established the triage protocols for emergency recognition. In this lesson, we move deeper into the management of <strong>Multi-System Organ Involvement (MSOI)</strong>. This is the "high-stakes" arena of the Autoimmune Specialist. When a client's condition moves from manageable joint pain or skin rashes to renal failure, pulmonary hypertension, or cardiac involvement, the margin for error disappears. You must transition from a primary wellness guide to a sophisticated coordinator of care.</p>
        </div>

        <h2 id="section1">1. Pathophysiology of Systemic Overflow</h2>
        <p>In most autoimmune cases, the immune system targets a specific tissue type (e.g., the myelin sheath in MS or the thyroid in Hashimotoâ€™s). However, in MSOI, the immune response becomes <span class="highlight">non-selective</span> or targets ubiquitous structures like the <strong>vascular endothelium</strong>. This is often referred to as "systemic overflow."</p>

        <p>The transition from localized to systemic involvement typically follows a three-stage mechanical failure:</p>
        <ol>
            <li><strong>Endothelial Activation:</strong> Chronic inflammatory cytokines (IL-6, TNF-alpha) damage the lining of the blood vessels, allowing immune complexes to deposit in high-pressure filtration sites (kidneys) or delicate gas-exchange sites (lungs).</li>
            <li><strong>Microvascular Injury:</strong> Small blood vessels undergo fibrinoid necrosis or proliferative changes, leading to tissue ischemia.</li>
            <li><strong>Cytokine Storm & Complement Activation:</strong> A feedback loop where damaged tissue releases further inflammatory signals, leading to a systemic "overload" that the body's regulatory T-cells (Tregs) can no longer contain.</li>
        </ol>

        <div class="stats-box">
            <div class="stat-grid">
                <div class="stat-item">
                    <div class="stat-number">60%</div>
                    <div class="stat-label">of SLE patients will develop renal involvement</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">15%</div>
                    <div class="stat-label">of Systemic Sclerosis patients face Renal Crisis</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">3.4x</div>
                    <div class="stat-label">Higher mortality in MSOI vs. localized AI</div>
                </div>
            </div>
        </div>

        <h2 id="section2">2. The Prototype: Lupus Nephritis (LN)</h2>
        <p>Lupus Nephritis is the gold standard for understanding MSOI. It occurs when anti-double-stranded DNA (dsDNA) antibodies form immune complexes that become trapped in the <span class="highlight">glomerulus</span> of the kidney. This triggers a massive inflammatory cascade (Type III Hypersensitivity).</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: Sarah G. (Lupus Nephritis)</p>
                    <p style="color:white; font-size:12px; margin:0;">Age: 31 | Condition: SLE with Stage IV Nephritis</p>
                </div>
            </div>
            <div class="case-study-content">
                <p><strong>Presenting Symptoms:</strong> Sarah presented with 3+ pitting edema in the lower extremities, foamy urine (proteinuria), and a sudden spike in blood pressure (165/105 mmHg). Her Rheumatologist confirmed a flare, but Sarah wanted integrative support to prevent total renal failure.</p>
                <p><strong>Intervention:</strong> While the medical team initiated Mycophenolate Mofetil and high-dose Prednisone, the Specialist focused on:</p>
                <ul>
                    <li><strong>Contain Inflammation (C):</strong> Strict low-sodium, kidney-protective AIP modification to reduce fluid retention and glomerular pressure.</li>
                    <li><strong>Address Root Causes (A):</strong> Testing revealed a high burden of <span class="highlight">mercury</span> (which has high affinity for renal tissue) and a latent EBV reactivation.</li>
                    <li><strong>Outcome:</strong> Sarah's proteinuria decreased from 3.5g/day to 0.4g/day over 6 months. By addressing the mercury and EBV, her medical team was able to taper her steroids faster than average.</li>
                </ul>
            </div>
        </div>

        <h2 id="section3">3. Vascular Emergencies: Scleroderma Renal Crisis (SRC)</h2>
        <p>While Lupus Nephritis is often an inflammatory "clogging" of the kidneys, <strong>Scleroderma Renal Crisis (SRC)</strong> is a vascular "explosion." It is characterized by sudden, severe hypertension and rapid-onset renal failure. The mechanism is the narrowing of the renal arteries, leading the kidneys to believe the body is in shock, which triggers a massive release of renin.</p>

        <div class="alert-box warning">
            <p class="alert-label">Critical Warning: SRC Recognition</p>
            <p>If a Scleroderma client reports a "thunderclap" headache, blurred vision, or a sudden rise in blood pressure, this is a <strong>medical emergency</strong>. SRC can lead to permanent dialysis or death within days if not treated with ACE inhibitors immediately. Practitioners must NEVER suggest "natural" blood pressure remedies in place of emergency medical intervention in this scenario.</p>
        </div>

        <h2 id="section4">4. Coordinating the Multidisciplinary Team (MDT)</h2>
        <p>In MSOI cases, the Specialist acts as the "Integrative Liaison." You are often the only person looking at the *whole* human while the specialists look at their respective organs. Effective communication is vital.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Specialist</th>
                        <th>Focus Area</th>
                        <th>Your Communication Goal</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Nephrologist</strong></td>
                        <td>GFR, Creatinine, Proteinuria</td>
                        <td>Discussing nephrotoxic supplements to avoid and fluid/electrolyte balance.</td>
                    </tr>
                    <tr>
                        <td><strong>Pulmonologist</strong></td>
                        <td>DLCO, FVC, Pulmonary Pressures</td>
                        <td>Focusing on anti-fibrotic nutrition and oxidative stress reduction in lung tissue.</td>
                    </tr>
                    <tr>
                        <td><strong>Rheumatologist</strong></td>
                        <td>Serology (ANA, dsDNA, Complement)</td>
                        <td>Sharing data on "Root Cause" findings (e.g., gut dysbiosis) that drive systemic flares.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section5">5. Advanced 'A': Root Causes of Systemic Cascades</h2>
        <p>Why does one person get a skin rash and another get renal failure? In the C.A.L.M. Protocolâ„¢, we look at the <span class="highlight">Toxic Load Threshold</span>. When MSOI occurs, it usually indicates that the body's primary emunctories (liver, gut, skin) are so overwhelmed that the "overflow" is hitting the secondary, more delicate organs.</p>
        
        <h3>Systemic Triggers to Investigate in MSOI:</h3>
        <ul>
            <li><strong>Molecular Mimicry (Pathogen-Led):</strong> Certain strains of <em>Klebsiella</em> or <em>Proteus</em> have been linked to cross-reactivity with renal and joint tissues.</li>
            <li><strong>Heavy Metal Affinity:</strong> Cadmium and Mercury concentrate in the kidneys (nephrotoxicity), while Silica is a known driver of Systemic Sclerosis.</li>
            <li><strong>Microvascular Biofilms:</strong> Chronic stealth infections (like Borrelia or Bartonella) can colonize the endothelium, triggering systemic vasculitis.</li>
        </ul>

        <h2 id="section6">6. Triage & Intervention Prioritization</h2>
        <p>When a client has five systems failing, you cannot address them all at once. You must follow the <strong>Hierarchy of Vitality</strong>:</p>
        
        <div class="key-terms-box">
            <div class="terms-grid">
                <div class="term-item">
                    <p class="term">Level 1: Vital Organs</p>
                    <p class="definition">Heart, Lungs, Kidneys. These require immediate medical stabilization. Your role is supportive (e.g., anti-inflammatory diet that doesn't stress the kidneys).</p>
                </div>
                <div class="term-item">
                    <p class="term">Level 2: Regulatory Systems</p>
                    <p class="definition">The HPA Axis and Nervous System. Once the crisis is stabilized, we must lower the "threat response" to prevent a rebound flare.</p>
                </div>
                <div class="term-item">
                    <p class="term">Level 3: Root Cause Resolution</p>
                    <p class="definition">Gut healing, toxin removal, and pathogen eradication. This is only done once the client is out of the "Crisis Zone."</p>
                </div>
            </div>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <p class="question-text">1. What is the primary difference in mechanism between Lupus Nephritis and Scleroderma Renal Crisis?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Lupus Nephritis is primarily an <strong>inflammatory/immune-complex</strong> deposition issue (Type III Hypersensitivity), whereas Scleroderma Renal Crisis is a <strong>vascular/obstructive</strong> issue leading to malignant hypertension and renin-angiotensin activation.</div>
            </div>
            <div class="question-item">
                <p class="question-text">2. Why is the "Address Root Causes" (A) phase of the C.A.L.M. Protocolâ„¢ modified during an active MSOI crisis?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">During a crisis, the body cannot handle the metabolic stress of aggressive detoxification or "die-off" (Herxheimer) reactions. The focus shifts to identifying triggers to *remove* them passively, rather than active eradication, until the vital organs are stable.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <h4>Key Takeaways</h4>
            <ul>
                <li><strong>Systemic Overflow</strong> occurs when localized immune responses fail and the vascular endothelium becomes the primary target.</li>
                <li><strong>Kidney involvement</strong> is the most common and dangerous form of MSOI in SLE and Scleroderma.</li>
                <li>The Specialist's role is to <strong>bridge the gap</strong> between medical specialists and provide the "whole-person" view.</li>
                <li>Never prioritize "natural" interventions over emergency medical care (ACE inhibitors, steroids, dialysis) during an active MSOI crisis.</li>
                <li>Long-term remission in MSOI requires addressing <strong>deep systemic triggers</strong> like heavy metals and stealth pathogens.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Hahn, B. H., et al. (2012). "American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis." <i>Arthritis Care & Research</i>.</li>
                <li>Steen, V. D. (2014). "Scleroderma renal crisis: 25 years later." <i>Seminars in Arthritis and Rheumatism</i>.</li>
                <li>Anders, H. J., et al. (2020). "The kidney in systemic lupus erythematosus." <i>Nature Reviews Nephrology</i>.</li>
                <li>Mok, C. C. (2016). "The epidemiology and cost of systemic lupus erythematosus." <i>Rheumatology (Oxford)</i>.</li>
                <li>Denton, C. P., et al. (2016). "BSR and BHPR guideline for the treatment of systemic sclerosis." <i>Rheumatology</i>.</li>
                <li>Tsokos, G. C. (2011). "Systemic lupus erythematosus." <i>New England Journal of Medicine</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Autoimmune Specialist Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All Rights Reserved. Confidential Professional Training Material.</p>
        </footer>
    </div>
</body>

</html>